We also tested whether CSF sTREM2 levels are associated with the core AD CSF biomarkers Aβ1–42, total tau (T‐tau) and tau phosphorylated at threonine 181 (P‐tau181P) (Blennow et al, 2010). The gene discussed is MAPT; the disease is Alzheimer disease.